We are live on
!
Find out more
HSA
HBK Sorce Advisory Portfolio holdings
AUM
$5.27B
1-Year Est. Return
19.34%
This Fund
S&P 500
This Quarter
Est. Return
-1.21%
1 Year Est. Return
+19.34%
3 Year Est. Return
+58.25%
5 Year Est. Return
+61.05%
10 Year Est. Return
+218.37%
AUM
$5.05B
AUM Growth
+$692M
(+16%)
Cap. Flow
+$490M
Cap. Flow
% of AUM
9.72%
Top 10 Holdings %
Top 10 Hldgs %
70.45%
Holding
704
New
76
Increased
317
Reduced
222
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VCRM
Vanguard Core Tax-Exempt Bond ETF
VCRM
|
+$237M |
| 2 |
Vanguard Core Bond ETF
VCRB
|
+$138M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$47.8M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$33.6M |
| 5 |
Booking.com
BKNG
|
+$17.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$23.9M |
| 2 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$8.86M |
| 3 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
+$2.21M |
| 4 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$1.34M |
| 5 |
Apple
AAPL
|
+$938K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.88% |
| 2 | Financials | 2.77% |
| 3 | Industrials | 1.93% |
| 4 | Communication Services | 1.82% |
| 5 | Healthcare | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Lexicon Pharmaceuticals
LXRX
$1.1B
| $23.6K | ﹤0.01% |
11,786
| – | – |
|
652
Innoviz Technologies
INVZ
$112M
| $22K | ﹤0.01% |
+30,088
| New | +$27.5K |
|
653
Sabre
SABR
$835M
| $20.9K | ﹤0.01% |
+10,144
| New | +$13.5K |
|
654
CALL
ON Semiconductor
ON
$31.6B
| $20.6K | ﹤0.01% |
+200
| New | +$12.6K |
|
|
DEFT
655
Defi Technologies
DEFT
$183M
| $20.6K | ﹤0.01% |
+28,310
| New | +$21.6K |
|
|
ABTC
656
American Bitcoin Corp
ABTC
$471M
| $18.6K | ﹤0.01% |
+1,039
| New | +$20K |
|
|
NVX
657
NOVONIX
NVX
$102M
| $16.9K | ﹤0.01% |
+24,015
| New | +$23.3K |
|
|
CAN
658
Canaan Creative
CAN
$159M
| $15.7K | ﹤0.01% |
+30,870
| New | +$18K |
|
659
Opko Health
OPK
$1.02B
| $12.6K | ﹤0.01% |
11,057
| – | – |
|
660
SES AI
SES
$208M
| $10.4K | ﹤0.01% |
11,210
| – | – |
|
661
Werewolf Therapeutics
HOWL
$19.3M
| $8.99K | ﹤0.01% |
13,227
| – | – |
|
662
NexGel
NXGL
$3.51M
| $7.42K | ﹤0.01% |
+12,500
| New | +$15.4K |
|
663
CXApp
CXAI
$17.5M
| $6.37K | ﹤0.01% |
+43,911
| New | +$10.9K |
|
664
GT Biopharma
GTBP
$11.5M
| $3.75K | ﹤0.01% |
10,000
| – | – |
|
665
Akebia Therapeutics
AKBA
$252M
| – | – |
-12,034
| Closed | -$16.7K |
|
666
Best Buy
BBY
$17.3B
| – | – |
-4,229
| Closed | -$298K |
|
|
BTA
667
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
| – | – |
-34,620
| Closed | -$334K |
|
668
Clorox
CLX
$12.7B
| – | – |
-2,837
| Closed | -$339K |
|
669
Carter's
CRI
$1.47B
| – | – |
-6,532
| Closed | -$240K |
|
|
CYBR
670
DELISTED
CyberArk
CYBR
| – | – |
-1,125
| Closed | -$441K |
|
671
Dollar General
DG
$27.9B
| – | – |
-1,443
| Closed | -$212K |
|
672
DTE Energy
DTE
$29.1B
| – | – |
-2,231
| Closed | -$301K |
|
673
Fate Therapeutics
FATE
$326M
| – | – |
-10,659
| Closed | -$12.2K |
|
|
FFWM
674
DELISTED
First Foundation Inc
FFWM
| – | – |
-15,739
| Closed | -$101K |
|
675
Fidelity MSCI Health Care Index ETF
FHLC
$3.36B
| – | – |
-2,850
| Closed | -$214K |
|
Similar funds
FMWA
DRZID
WL
SDIC
DDC
KACA
DPL
AUB
HBK Sorce Advisory's Q1 2026 Portfolio in Review
As of Q1 2026, HBK Sorce Advisory held 704 positions worth $5.05B, up 16% from $4.35B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
HBK Sorce Advisory deployed $490M of net new capital in Q1 2026, opening 76 new positions and adding to 317 existing holdings. Its largest new stake was AstraZeneca: 4,017 shares worth $735K.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 5.9% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $23.9M trimmed.
- HBK Sorce Advisory's largest Q1 2026 buy was AstraZeneca: 4,017 shares worth $735K.
- HBK Sorce Advisory added most to Vanguard Core Tax-Exempt Bond ETF in Q1 2026, an estimated $237M increase.
- HBK Sorce Advisory's biggest Q1 2026 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $23.9M.
- HBK Sorce Advisory fully exited iShares National Muni Bond ETF in Q1 2026, selling an estimated $817K.
- HBK Sorce Advisory's ten largest holdings make up 70% of its $5.05B portfolio in Q1 2026.
- HBK Sorce Advisory opened 76 new positions and closed 40 in Q1 2026.
- HBK Sorce Advisory's portfolio value rose 16% quarter-over-quarter to $5.05B.
Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.